[시장보고서]세계의 수의용 정맥 주입액 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 적응증별, 동물 유형별, 최종 용도별, 지역별, 경쟁별(2020-2030년)

세계의 수의용 정맥 주입액 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 적응증별, 동물 유형별, 최종 용도별, 지역별, 경쟁별(2020-2030년)

Veterinary Intravenous Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By Animal type, By End Use, By Region & Competition, 2020-2030F

상품코드 : 1743730

리서치사 : TechSci Research

발행일 : 2025년 06월

페이지 정보 : 영문 182 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,513,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 7,960,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,579,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 수의용 정맥 주입액 시장은 2024년에는 13억 5,000만 달러로 평가되었고, 예측 기간 중의 CAGR은 6.57%로 성장할 전망입니다.

이 성장은 수의학 분야의 기술 발전과 인간 의료 분야의 트렌드를 반영한 것으로, IV 용액이 치료 프로토콜의 핵심 요소로 자리 잡은 점을 반영합니다. 수의용 정맥 주입액은 다양한 동물 종에서 수분 공급, 약물 투여, 중환자 치료에 필수적입니다. 전 세계 반려동물 소유율 증가, 동물 돌봄에 대한 기대치 상승, 보험 가입 반려동물 수의 증가가 이 수요 급증의 주요 요인입니다. 이 솔루션은 일상적인 상황과 응급 상황 모두에서 사용되며, 수의학 환경에서 회복과 치료 효과를 지원합니다. 인간과 동물 간의 유대감이 강화되고 반려동물 관리가 더욱 정교해짐에 따라 신뢰성 있고 효과적인 정맥 내 치료에 대한 수요가 계속 증가하며, 이는 전 세계 시장 확장을 이끌고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모(2024년)	13억 5,000만 달러
시장 규모(2030년)	19억 6,000만 달러
CAGR(2025-2030년)	6.57%
급성장 부문	반려동물
최대 시장	북미

주요 시장 성장 촉진요인

반려동물 소유율 증가와 인간화 추세가 세계의 수의용 정맥 주입액 시장을 주도

주요 시장 과제

제한된 연구 및 제형 다양성이 시장 확장 장애물로 작용

주요 시장 동향

기술 진보

시장 규모와 예측
- 금액별
시장 점유율 및 예측
- 제품별(등장성 결정질 용액, 합성콜로이드, 혈액제제, 포도당액, 정맥 영양제)
- 적응증별(당뇨병성 케톤산증, 췌장염, 탄저병, 만성 신장병, 기타)
- 동물 유형별(반려동물, 생산 동물)
- 용도별(동물병원, 연구기관, 기타)
- 지역별
- 기업별(시장 상위 5개사 점유율)
시장 맵
- 제품별
- 적응증별
- 동물 유형별
- 최종 용도별
- 지역별

제6장 북미의 수의용 정맥 주입액 시장 전망

시장 규모와 예측
시장 점유율 및 예측

제7장 유럽의 수의용 정맥 주입액 시장 전망

시장 규모와 예측
시장 점유율 및 예측

제8장 아시아태평양의 수의용 정맥 주입액 시장 전망

시장 규모와 예측
시장 점유율 및 예측

제9장 남미의 수의용 정맥 주입액 시장 전망

시장 규모와 예측
시장 점유율 및 예측

제10장 중동 및 아프리카의 수의용 정맥 주입액 시장 전망

시장 규모와 예측
시장 점유율 및 예측

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

최근 동향
합병과 인수
제품 출시

제13장 경쟁 구도

Merck & Co., Inc.
Dechra Veterinary Products
Sypharma
Animalcare
B. Braun SE
Woods Consulting, LLC
Baxter International
Fresenius Kabi

제14장 전략적 제안

제15장 기업 소개와 면책사항

HBR

영문 목차

영문목차

The Global Veterinary Intravenous (IV) Solutions Market was valued at USD 1.35 billion in 2024 and is projected to expand significantly, reaching new heights by 2030 with a CAGR of 6.57% during the forecast period. This growth reflects advancements in veterinary medicine, mirroring trends in human healthcare, where IV solutions are integral to treatment protocols. Veterinary IV solutions are crucial for hydration, medication delivery, and critical care across a variety of animal species. Increasing global pet ownership, heightened expectations for animal care, and the growing number of insured pets-such as the 6.25 million pets reported insured in North America in 2024-are major contributors to this surge in demand. These solutions are used in both routine and emergency situations, supporting recovery and treatment efficacy in veterinary settings. As the human-animal bond deepens and pet care becomes more sophisticated, the need for reliable, effective IV therapies continues to grow, driving market expansion worldwide.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.35 Billion
Market Size 2030	USD 1.96 Billion
CAGR 2025-2030	6.57%
Fastest Growing Segment	Companion Animal
Largest Market	North America

Key Market Drivers

Rising Pet Ownership and Humanization is Driving the Global Veterinary Intravenous (IV) Solutions Market

The rapid increase in global pet ownership and the growing trend of treating pets as family members are significantly boosting demand for veterinary healthcare services, including IV solutions. In the U.S., approximately 67% of households own a pet, a trend echoed in many other regions. This humanization of pets has transformed the way owners approach healthcare, prompting greater interest in advanced medical treatments similar to those used for humans. Veterinary IV solutions, vital for administering fluids, medications, and nutrients during critical care, are increasingly in demand as pet owners seek comprehensive and high-quality medical support. The surge in pet insurance coverage also supports this growth by making advanced veterinary treatments more financially accessible, encouraging more pet owners to opt for intensive interventions that include IV therapy.

Key Market Challenges

Limited Research and Formulation Variety Poses a Significant Obstacle To Market Expansion

A significant challenge facing the veterinary IV solutions market is the limited research and formulation diversity tailored to various animal species. Unlike human IV solutions, which benefit from extensive R&D and specificity, veterinary formulations often lack the same level of customization. This is particularly problematic for exotic and less common species that have unique physiological needs not addressed by standard formulations. The limited number of species-specific products restricts veterinarians' ability to deliver optimal care, which can impact treatment outcomes. This gap in product variety hinders market expansion and highlights the need for increased investment in research to develop a broader range of targeted IV solutions across diverse animal categories.

Key Market Trends

Technological Advancements

The integration of precision medicine and digital health technologies is reshaping the veterinary IV solutions market. Diagnostic innovations, such as genetic testing, allow for the formulation of personalized IV therapies, improving treatment effectiveness and patient outcomes. Telemedicine platforms and remote monitoring tools are also revolutionizing care delivery, enabling veterinarians to track patient vitals and modify IV regimens in real time without in-person visits. Moreover, smart infusion pumps and automated delivery systems enhance accuracy and safety by precisely controlling fluid and medication administration. These systems can adapt dosages dynamically based on live data. The adoption of digital health records and analytics further supports data-driven treatment decisions, improving care outcomes and contributing to the evolution of more targeted, efficient, and intelligent veterinary healthcare protocols.

Key Market Players

Merck & Co., Inc.
Dechra Veterinary Products
Sypharma Pty Ltd.
Animalcare group plc
Braun SE
Woods Consulting, LLC
Baxter International
Fresenius Kabi

Report Scope:

In this report, the Global Veterinary Intravenous (IV) Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Intravenous (IV) Solutions Market, By Product:

Isotonic crystalloids
Synthetic colloids
Blood products
Dextrose solutions
Parenteral nutrition

Veterinary Intravenous (IV) Solutions Market, By Indication:

Diabetic Ketoacidosis
Pancreatitis
Anthrax
Chronic Kidney Disease
Others

Veterinary Intravenous (IV) Solutions Market, By Animal Type:

Companion Animals
Production Animals

Veterinary Intravenous (IV) Solutions Market, By End Use:

Veterinary Hospitals
Research Institutes
Others

Veterinary Intravenous (IV) Solutions Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Intravenous (IV) Solutions Market.

Available Customizations:

Global Veterinary Intravenous (IV) Solutions Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Intravenous (IV) Solutions Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose solutions, Parenteral nutrition)
- 5.2.2. By Indication (Diabetic Ketoacidosis, Pancreatitis, Anthrax, Chronic Kidney Disease, Others)
- 5.2.3. By Animal type (Companion Animals, Production Animals)
- 5.2.4. By End Use (Veterinary Hospitals, Research Institutes, Others)
- 5.2.5. By Region
- 5.2.6. By Company (Shares of Top 5 Market Players)
5.3. Market Map
- 5.3.1. By Product
- 5.3.2. By Indication
- 5.3.3. By Animal type
- 5.3.4. By End Use
- 5.3.5. By Region

6. North America Veterinary Intravenous (IV) Solutions Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Indication
- 6.2.3. By Animal type
- 6.2.4. By End Use
- 6.2.5. By Country
  - 6.2.5.1. United States Veterinary Intravenous (IV) Solutions Market Outlook
    - 6.2.5.1.1. Market Size & Forecast
    - 6.2.5.1.1.1. By Value
    - 6.2.5.1.2. Market Share & Forecast
    - 6.2.5.1.2.1. By Product
    - 6.2.5.1.2.2. By Indication
    - 6.2.5.1.2.3. By Animal type
    - 6.2.5.1.2.4. By End Use
  - 6.2.5.2. Canada Veterinary Intravenous (IV) Solutions Market Outlook
    - 6.2.5.2.1. Market Size & Forecast
    - 6.2.5.2.1.1. By Value
    - 6.2.5.2.2. Market Share & Forecast
    - 6.2.5.2.2.1. By Product
    - 6.2.5.2.2.2. By Indication
    - 6.2.5.2.2.3. By Animal type
    - 6.2.5.2.2.4. By End Use
  - 6.2.5.3. Mexico Veterinary Intravenous (IV) Solutions Market Outlook
    - 6.2.5.3.1. Market Size & Forecast
    - 6.2.5.3.1.1. By Value
    - 6.2.5.3.2. Market Share & Forecast
    - 6.2.5.3.2.1. By Product
    - 6.2.5.3.2.2. By Indication
    - 6.2.5.3.2.3. By Animal type
    - 6.2.5.3.2.4. By End Use

7. Europe Veterinary Intravenous (IV) Solutions Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Indication
- 7.2.3. By Animal type
- 7.2.4. By End Use
- 7.2.5. By Country
  - 7.2.5.1. France Veterinary Intravenous (IV) Solutions Market Outlook
    - 7.2.5.1.1. Market Size & Forecast
    - 7.2.5.1.1.1. By Value
    - 7.2.5.1.2. Market Share & Forecast
    - 7.2.5.1.2.1. By Product
    - 7.2.5.1.2.2. By Indication
    - 7.2.5.1.2.3. By Animal type
    - 7.2.5.1.2.4. By End Use
  - 7.2.5.2. Germany Veterinary Intravenous (IV) Solutions Market Outlook
    - 7.2.5.2.1. Market Size & Forecast
    - 7.2.5.2.1.1. By Value
    - 7.2.5.2.2. Market Share & Forecast
    - 7.2.5.2.2.1. By Product
    - 7.2.5.2.2.2. By Indication
    - 7.2.5.2.2.3. By Animal type
    - 7.2.5.2.2.4. By End Use
  - 7.2.5.3. United Kingdom Veterinary Intravenous (IV) Solutions Market Outlook
    - 7.2.5.3.1. Market Size & Forecast
    - 7.2.5.3.1.1. By Value
    - 7.2.5.3.2. Market Share & Forecast
    - 7.2.5.3.2.1. By Product
    - 7.2.5.3.2.2. By Indication
    - 7.2.5.3.2.3. By Animal type
    - 7.2.5.3.2.4. By End Use
  - 7.2.5.4. Italy Veterinary Intravenous (IV) Solutions Market Outlook
    - 7.2.5.4.1. Market Size & Forecast
    - 7.2.5.4.1.1. By Value
    - 7.2.5.4.2. Market Share & Forecast
    - 7.2.5.4.2.1. By Product
    - 7.2.5.4.2.2. By Indication
    - 7.2.5.4.2.3. By Animal type
    - 7.2.5.4.2.4. By End Use
  - 7.2.5.5. Spain Veterinary Intravenous (IV) Solutions Market Outlook
    - 7.2.5.5.1. Market Size & Forecast
    - 7.2.5.5.1.1. By Value
    - 7.2.5.5.2. Market Share & Forecast
    - 7.2.5.5.2.1. By Product
    - 7.2.5.5.2.2. By Indication
    - 7.2.5.5.2.3. By Animal type
    - 7.2.5.5.2.4. By End Use

8. Asia Pacific Veterinary Intravenous (IV) Solutions Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Indication
- 8.2.3. By Animal type
- 8.2.4. By End Use
- 8.2.5. By Country
  - 8.2.5.1. China Veterinary Intravenous (IV) Solutions Market Outlook
    - 8.2.5.1.1. Market Size & Forecast
    - 8.2.5.1.1.1. By Value
    - 8.2.5.1.2. Market Share & Forecast
    - 8.2.5.1.2.1. By Product
    - 8.2.5.1.2.2. By Indication
    - 8.2.5.1.2.3. By Animal type
    - 8.2.5.1.2.4. By End Use
  - 8.2.5.2. India Veterinary Intravenous (IV) Solutions Market Outlook
    - 8.2.5.2.1. Market Size & Forecast
    - 8.2.5.2.1.1. By Value
    - 8.2.5.2.2. Market Share & Forecast
    - 8.2.5.2.2.1. By Product
    - 8.2.5.2.2.2. By Indication
    - 8.2.5.2.2.3. By Animal type
    - 8.2.5.2.2.4. By End Use
  - 8.2.5.3. South Korea Veterinary Intravenous (IV) Solutions Market Outlook
    - 8.2.5.3.1. Market Size & Forecast
    - 8.2.5.3.1.1. By Value
    - 8.2.5.3.2. Market Share & Forecast
    - 8.2.5.3.2.1. By Product
    - 8.2.5.3.2.2. By Indication
    - 8.2.5.3.2.3. By Animal type
    - 8.2.5.3.2.4. By End Use
  - 8.2.5.4. Japan Veterinary Intravenous (IV) Solutions Market Outlook
    - 8.2.5.4.1. Market Size & Forecast
    - 8.2.5.4.1.1. By Value
    - 8.2.5.4.2. Market Share & Forecast
    - 8.2.5.4.2.1. By Product
    - 8.2.5.4.2.2. By Indication
    - 8.2.5.4.2.3. By Animal type
    - 8.2.5.4.2.4. By End Use
  - 8.2.5.5. Australia Veterinary Intravenous (IV) Solutions Market Outlook
    - 8.2.5.5.1. Market Size & Forecast
    - 8.2.5.5.1.1. By Value
    - 8.2.5.5.2. Market Share & Forecast
    - 8.2.5.5.2.1. By Product
    - 8.2.5.5.2.2. By Indication
    - 8.2.5.5.2.3. By Animal type
    - 8.2.5.5.2.4. By End Use

9. South America Veterinary Intravenous (IV) Solutions Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Indication
- 9.2.3. By Animal type
- 9.2.4. By End Use
- 9.2.5. By Country
  - 9.2.5.1. Brazil Veterinary Intravenous (IV) Solutions Market Outlook
    - 9.2.5.1.1. Market Size & Forecast
    - 9.2.5.1.1.1. By Value
    - 9.2.5.1.2. Market Share & Forecast
    - 9.2.5.1.2.1. By Product
    - 9.2.5.1.2.2. By Indication
    - 9.2.5.1.2.3. By Animal type
    - 9.2.5.1.2.4. By End Use
  - 9.2.5.2. Argentina Veterinary Intravenous (IV) Solutions Market Outlook
    - 9.2.5.2.1. Market Size & Forecast
    - 9.2.5.2.1.1. By Value
    - 9.2.5.2.2. Market Share & Forecast
    - 9.2.5.2.2.1. By Product
    - 9.2.5.2.2.2. By Indication
    - 9.2.5.2.2.3. By Animal type
    - 9.2.5.2.2.4. By End Use
  - 9.2.5.3. Colombia Veterinary Intravenous (IV) Solutions Market Outlook
    - 9.2.5.3.1. Market Size & Forecast
    - 9.2.5.3.1.1. By Value
    - 9.2.5.3.2. Market Share & Forecast
    - 9.2.5.3.2.1. By Product
    - 9.2.5.3.2.2. By Indication
    - 9.2.5.3.2.3. By Animal type
    - 9.2.5.3.2.4. By End Use

10. Middle East & Africa Veterinary Intravenous (IV) Solutions Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Indication
- 10.2.3. By Animal type
- 10.2.4. By End Use
- 10.2.5. By Country
  - 10.2.5.1. South Africa Veterinary Intravenous (IV) Solutions Market Outlook
    - 10.2.5.1.1. Market Size & Forecast
    - 10.2.5.1.1.1. By Value
    - 10.2.5.1.2. Market Share & Forecast
    - 10.2.5.1.2.1. By Product
    - 10.2.5.1.2.2. By Indication
    - 10.2.5.1.2.3. By Animal type
    - 10.2.5.1.2.4. By End Use
  - 10.2.5.2. Saudi Arabia Veterinary Intravenous (IV) Solutions Market Outlook
    - 10.2.5.2.1. Market Size & Forecast
    - 10.2.5.2.1.1. By Value
    - 10.2.5.2.2. Market Share & Forecast
    - 10.2.5.2.2.1. By Product
    - 10.2.5.2.2.2. By Indication
    - 10.2.5.2.2.3. By Animal type
    - 10.2.5.2.2.4. By End Use
  - 10.2.5.3. UAE Veterinary Intravenous (IV) Solutions Market Outlook
    - 10.2.5.3.1. Market Size & Forecast
    - 10.2.5.3.1.1. By Value
    - 10.2.5.3.2. Market Share & Forecast
    - 10.2.5.3.2.1. By Product
    - 10.2.5.3.2.2. By Indication
    - 10.2.5.3.2.3. By Animal type
    - 10.2.5.3.2.4. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Competitive Landscape

13.1. Merck & Co., Inc.
- 13.1.1. Business Overview
- 13.1.2. Company Snapshot
- 13.1.3. Products & Service
- 13.1.4. Financials (As Reported)
- 13.1.5. Recent Developments
- 13.1.6. Key Personnel Details
- 13.1.7. SWOT Analysis
13.2. Dechra Veterinary Products
13.3. Sypharma
13.4. Animalcare
13.5. B. Braun SE
13.6. Woods Consulting, LLC
13.7. Baxter International
13.8. Fresenius Kabi